Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Pivmecillinam 185 mg TID for 5 days, taken orally with or without food”In the company’s words, NCT07871968 on ClinicalTrials.gov
- Tested for
- Uncomplicated Urinary Tract Infections
- Main trialPhase 2
- “Multicenter, Randomized, Open-label, Active-controlled Study with Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride versus Nitrofurantoin for the Treatment of Female Pediatric Subjects, 12 Years to Less Than 18 Years of Age, with Uncomplicated Urinary Tract Infections”In the company’s words, NCT07871968 on ClinicalTrials.gov
Other drugs for Uncomplicated Urinary Tract Infections
- U101TCM Biotech International Corp. · Phase 3
- Candidate UTI vaccineGSK · Phase 1/2
- LBP-EC01Locus Biosciences · Phase 2
- GepotidacinGSK · Phase 1
- JKN2501Joincare Pharmaceutical Group Industry Co., Ltd · Phase 1
Coming up1
- 30 Oct 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 30 Oct 2027 | A Study to Investigate Pivmecillinam Versus Nitrofurantoin in Female Adolescents 12 to Less Than 18 Years of Age With Uncomplicated Urinary Tract Infection |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026